Related Experiment Video
Updated: Sep 22, 2025

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations
Ashley S Doane1, Olivier Elemento1
1Caryl and Israel Englander Institute for Precision Medicine, Institute for Computational Biomedicine, Weill Cornell Medicine, United States.
Abstract:
Aberrant gene expression is a cancer hallmark and it is known that almost every tumor acquires somatic mutations in transcription factors, chromatin regulators, or the DNA regulatory elements that are critical for transcriptional control and cell phenotype. While the role of transcription factors and chromatin regulators has been widely studied, relatively few noncoding driver mutations have been identified and functionally characterized to date. Here, we review the current understanding of somatic variants in noncoding regions of the cancer genome and their impact on chromatin architecture and transcriptional networks. We also discuss approaches and ongoing challenges for noncoding driver discovery, and highlight insights gained from recent studies exploring the nature and impact of noncoding drivers on tumor formation.
Insights
Cancer cells often have altered gene expression due to mutations. This review focuses on noncoding somatic mutations, their effects on gene regulation, and challenges in identifying these cancer drivers.
Area of Science:
- Genomics
- Cancer Biology
- Epigenetics
Background:
- Aberrant gene expression is a hallmark of cancer.
- Somatic mutations in transcription factors and chromatin regulators are well-studied cancer drivers.
- However, noncoding somatic mutations impacting transcriptional control are less understood.
Purpose of the Study:
- To review the current understanding of somatic variants in noncoding cancer genomes.
- To discuss their impact on chromatin architecture and transcriptional networks.
- To highlight challenges and insights in noncoding driver discovery.
Main Methods:
- Literature review of recent studies on noncoding cancer genome variants.
- Analysis of impacts on chromatin and gene expression.
- Discussion of methodologies for driver discovery.
Main Results:
- Noncoding somatic variants can significantly alter cancer cell phenotype.
- These variants affect chromatin architecture and transcriptional networks.
- Identifying and characterizing noncoding drivers remains a challenge.
Conclusions:
- Noncoding somatic mutations are crucial, yet understudied, contributors to cancer.
- Further research is needed to fully elucidate their role and therapeutic potential.
- Advances in genomic analysis are improving noncoding driver discovery.
More Related Videos
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

